Akio Mori
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease.
Journal: Journal of Parkinson's disease
Published: April 26, 2021
Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.
Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease.
Journal: International journal of molecular sciences
Published: April 02, 2020
The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1.
Journal: Neurobiology of aging
Published: March 05, 2020
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 17, 2019
Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.
Journal: Annals of clinical and translational neurology
Published: September 28, 2019
Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 25, 2019
Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease.
Journal: Stem cell reports
Published: September 24, 2019
Mutations in CHCHD2 cause α-synuclein aggregation.
Journal: Human molecular genetics
Published: May 30, 2019
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.
Journal: PloS one
Published: April 16, 2019
Metabolomics-based identification of metabolic alterations in PARK2.
Journal: Annals of clinical and translational neurology
Published: December 28, 2018
A metabolic profile of polyamines in parkinson disease: A promising biomarker.
Journal: Annals of neurology
Published: December 27, 2018
Neuromelanin or DaT-SPECT: which is the better marker for discriminating advanced Parkinson's disease?
Journal: European journal of neurology
Published: November 27, 2018
Last Updated: 09/26/2026